SharePost Content Read More Yahoo Finance #finance Post navigation Infosys Stock Halted After Massive Gain—and No One Knows What Prompted the Move BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.
